Assessment of bioabsorbable implant treatment for nasal valve collapse compared to a sham group: a randomized control trial
Open Access
- 21 June 2019
- journal article
- research article
- Published by Wiley in International Forum of Allergy & Rhinology
- Vol. 9 (8) , 850-856
Abstract
Background: Dynamic nasal valve collapse (NVC) is a common factor contributing to nasal obstruction; however, it is often underdiagnosed and untreated. An in‐office, minimally invasive procedure addressing dynamic NVC uses a bioabsorbable implant (Latera) to support the lateral nasal wall. This study aimed to evaluate the safety and effectiveness of the treatment in a randomized controlled trial (RCT) with sham control.Methods: In this prospective, multicenter, single‐blinded RCT, 137 patients from 10 clinics were randomized into 2 arms: treatment arm (70 patients) and sham control arm (67 patients). Outcome measures were followed through 3 months after the procedure. The primary endpoint was the responder rate (percentage of patients with reduction in clinical severity by ≥1 category or ≥20% reduction in Nasal Obstruction Symptom Evaluation [NOSE] score).Results: Before the procedure, there were no statistically significant differences in patient demographics and nasal obstruction symptom measures between the 2 arms. Three months after the procedure, responder rate was significantly higher for the treatment arm compared to the control (82.5% vs 54.7%, p = 0.001). Patients in the treatment arm also had a significantly greater decrease in NOSE score (–42.4 ± 23.4 vs –22.7 ± 27.9, p < 0.0001) and significantly lower visual analogue scale (VAS) scores (–39.0 ± 29.7 vs –13.3 ± 30.0, p < 0.0001) than the sham control arm. Seventeen patients reported 19 procedure/implant‐related adverse events, all of which resolved with no clinical sequelae.Conclusion: Our study shows the safety and effectiveness of the bioabsorbable implant in reducing patients’ nasal obstruction symptoms.Keywords
Funding Information
- Stryker ENT
This publication has 25 references indexed in Scilit:
- Clinical consensus statement: Diagnosis and management of nasal valve compromiseOtolaryngology–Head and Neck Surgery, 2010
- Randomized trial of the effect of drug presentation on asthma outcomes: The American Lung Association Asthma Clinical Research CentersJournal of Allergy and Clinical Immunology, 2009
- Outcomes after Nasal Septoplasty: Results from the Nasal Obstruction Septoplasty Effectiveness (NOSE) StudyOtolaryngology–Head and Neck Surgery, 2004
- Radiofrequency Treatment of Turbinate Hypertrophy: A Randomized, Blinded, Placebo‐Controlled Clinical TrialOtolaryngology–Head and Neck Surgery, 2004
- Development and Validation of the Nasal Obstruction Symptom Evaluation (NOSE) Scale1Otolaryngology–Head and Neck Surgery, 2004
- Radiofrequency Treatment of Turbinate Hypertrophy in Subjects Using Continuous Positive Airway Pressure: A Randomized, Double‐Blind, Placebo‐Controlled Clinical Pilot TrialThe Laryngoscope, 2001
- Do medical devices have enhanced placebo effects?Journal of Clinical Epidemiology, 2000
- The Ethical Problems with Sham Surgery in Clinical ResearchNew England Journal of Medicine, 1999
- Surgery of the incompetent nasal valveThe Laryngoscope, 1985
- Spreader GraftPlastic and Reconstructive Surgery, 1984